(NASDAQ: FLGT) Fulgent Genetics's forecast annual revenue growth rate of 5.3% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Fulgent Genetics's revenue in 2024 is $289,213,000.On average, 2 Wall Street analysts forecast FLGT's revenue for 2024 to be $8,308,312,947, with the lowest FLGT revenue forecast at $8,274,209,384, and the highest FLGT revenue forecast at $8,342,416,509. On average, 2 Wall Street analysts forecast FLGT's revenue for 2025 to be $9,733,663,163, with the lowest FLGT revenue forecast at $9,355,396,571, and the highest FLGT revenue forecast at $10,111,929,755.
In 2026, FLGT is forecast to generate $10,519,981,117 in revenue, with the lowest revenue forecast at $10,519,981,117 and the highest revenue forecast at $10,519,981,117.